These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7094845)
1. Hepatitis and hemolytic anemia associated with methyldopa therapy. Breland BD; Hicks GS Drug Intell Clin Pharm; 1982 Jun; 16(6):489-92. PubMed ID: 7094845 [TBL] [Abstract][Full Text] [Related]
2. Methyldopa-induced immune hemolytic anemia and chronic active hepatitis. Shalev O; Mosseri M; Ariel I; Stalnikowicz R Arch Intern Med; 1983 Mar; 143(3):592-3. PubMed ID: 6830396 [TBL] [Abstract][Full Text] [Related]
3. Methyldopa Hepatitis. A report of six cases and review of the literature. Rodman JS; Deutsch DJ; Gutman SI Am J Med; 1976 Jun; 60(7):941-8. PubMed ID: 937354 [TBL] [Abstract][Full Text] [Related]
4. [Adverse effects of methyldopa during a 10-year period]. Lakartidningen; 1977 May; 74(21):2108-9. PubMed ID: 865184 [No Abstract] [Full Text] [Related]
5. Methyldopa-induced hemolytic anemia in a 15 year old presenting as near-syncope. Naidorf JS; Kennedy JM; Becher JW Pediatr Emerg Care; 1990 Mar; 6(1):29-32. PubMed ID: 2320485 [TBL] [Abstract][Full Text] [Related]
6. Congestive heart failure and respiratory arrest secondary to methyldopa-induced hemolytic anemia. Egbert D; Hendricksen DK Ann Emerg Med; 1988 May; 17(5):526-8. PubMed ID: 3364834 [TBL] [Abstract][Full Text] [Related]